SureTrader SureTrader SureTrader
Home > Boards > US Listed > Biotechs >

Novavax (NVAX)

NVAX RSS Feed
Add NVAX Price Alert      Hide Sticky   Hide Intro
Moderator: XenaLives
Search This Board:
Last Post: 1/19/2017 7:22:58 PM - Followers: 190 - Board type: Free - Posts Today: 0

ABOUT NOVAVAX:

Novavax, Inc. (Nasdaq: NVAX) is a clinical-stage biopharmaceutical company creating recombinant protein nanoparticle vaccines to address a broad range of infectious diseases. The company is developing a portfolio of vaccine candidates targeting seasonal and pandemic influenza (H5N1), a vaccine designed to protect children and the elderly against respiratory syncytial virus (RSV), rabies and other candidates. In addition, the company is developing its vaccine candidates for worldwide commercialization including:

Our world-class scientific team is using VLP technology to tackle influenza viruses – including avian strains that have the potential to cause a pandemic outbreak. Our team has created vaccine candidates that are in various phases of clinical testing designed to protect against various circulating strains of pandemic influenza including H1N1 and H5N1, as well as seasonal influenza. Our recombinant nanoparticle protein micelle technology targeted at RSV has been tested in various preclinical studies and has now advanced into clinical testing.

Our vision is to control the spread of infectious diseases by using a unique single-use manufacturing system that allows for the rapid mass production of recombinant protein nanoparticle vaccines. Our goal is to be able to rapidly deliver a customized vaccine in the midst of a declared pandemic.
 


MANAGEMENT TEAM:

President and Chief Executive Officer
Stanley C. Erck

Senior Vice President, Research and Development
Gregory M. Glenn, M.D.

Senior Vice President, Manufacturing and Process Development
Timothy J. Hahn, Ph.D.

Senior Vice President, Chief Financial Officer and Treasurer
Barclay A. "Buck" Phillips

Senior Vice President, Business Development
Russell P. "Rip" Wilson

Vice President, Regulatory Affairs
Amy B. Fix

Vice President, Chief Medical Officer
Louis F. Fries III, M.D.

Vice President, Manufacturing
Mervyn L. Hamer

Vice President, General Counsel and Corporate Secretary
John A. Herrmann III, J.D.

Vice President, Process Development
Erica Shane, Ph.D.

Vice President, Vaccine Development
Gale Smith, Ph.D.

Vice President, Clinical Operations
D. Nigel Thomas, Ph.D.

 

CLINICAL-STAGE PIPELINE:

Novavax’s clinical program includes vaccine candidates designed to address infectious diseases worldwide. Using innovative virus-like particle (VLP) and recombinant nanoparticle technology, as well as new and efficient manufacturing approaches, the company produces vaccine candidates to combat diseases, with the goal of allowing countries to better prepare for and more effectively respond to rapidly spreading infections. Our clinical pipeline is shown below.

 
ADJUVANT PIPELINE:

 

 
CHARTS:



 


LINKS:

http://www.novavax.com/
http://finance.yahoo.com/q/h?s=NVAX
http://www.novavax.com/download/File/Interphex.pdf
http://www.sec.gov/cgi-bin/browse-edgar?company=Novavax&CIK=&filenum=&State=&SIC=&owner=include&action=getcompany
http://www.wipo.int/pctdb/en/wo.jsp?WO=2008061243

 
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
NVAX
Current Price
Volume:
Bid Ask Day's Range
SureTrader
NVAX News: Notice of Effectiveness (effect) 01/20/2017 06:02:09 AM
NVAX News: Novavax Initiates Phase 2 Safety and Immunogenicity Trial of the RSV F Vaccine in Older Adults 01/19/2017 04:05:44 PM
NVAX News: Novavax Initiates Phase 2 Safety and Immunogenicity Trial of the RSV F Vaccine in Older Adults 01/19/2017 04:05:00 PM
NVAX News: Securities Registration Statement (simplified Form) (s-3/a) 01/13/2017 05:06:38 PM
NVAX News: Novavax to Present at the 35th Annual J.P. Morgan Healthcare Conference 01/05/2017 08:05:29 AM
PostSubject
#3770   YES SIR bleu22 01/19/17 07:22:57 PM
#3769   I posted some ago that this was a tiv111 01/19/17 07:04:20 PM
#3768   I'm still in it... no rush :) Santo 01/19/17 06:25:30 PM
#3767   News out, finally bleu22 01/19/17 04:24:27 PM
#3766   Dropped to $1.35 so far. I'm getting an ulcer Dgoff 01/19/17 12:36:20 PM
#3765   That's what I opined last week..."Raising capital...New Shares". Gup80 01/19/17 11:59:04 AM
#3764   Fingers crossed my friend Dgoff 01/19/17 10:38:35 AM
#3763   The news that their drug has potential to bleu22 01/19/17 10:36:04 AM
#3762   I agree, something going on with this company, Dgoff 01/19/17 09:39:58 AM
#3761   Or funds transferring, something going on, that's for sure. bleu22 01/19/17 09:28:29 AM
#3760   I can't tell by reading that for sure superstop 01/18/17 06:47:18 PM
#3759   Nice run up @ close bleu22 01/18/17 04:42:44 PM
#3758   IMO, smart shorts slowly covering. We will see SOOOON. bleu22 01/17/17 12:07:05 PM
#3757   something is cooking $NVAX avtges 01/17/17 11:18:05 AM
#3756   Securities Registration Statement (simplified Form) (s-3/a) Source: Edgar (US bleu22 01/14/17 02:49:25 PM
#3755   News? What news? r clarke 01/14/17 10:06:03 AM
#3754   What does today's news mean in English, anybody know? bleu22 01/13/17 08:45:14 PM
#3753   has met resistance at 1.47 last two times. simba1 01/12/17 02:49:55 PM
#3752   We need to push through 1.45 and 1.50 bleu22 01/12/17 02:01:22 PM
#3751   sgmo gets orphan drug approval,,,we next kingsransome 01/11/17 08:12:35 AM
#3750   No, just authorized for future use, IMO, huge bleu22 01/10/17 12:28:21 PM
#3749   chart looking so good 6 green candle steez 01/10/17 12:14:16 PM
#3748   Raising capital...new shares. Gup80 01/10/17 12:14:11 PM
#3747   yes this will run big lots steez 01/10/17 12:12:40 PM
#3746   11:08:53 bleu22 01/10/17 12:11:11 PM
#3745   176,000 buy just ran through bleu22 01/10/17 12:10:38 PM
#3744   Support looks good to bleu22 01/10/17 11:17:07 AM
#3743   check all the buys going on weeeeeee steez 01/10/17 11:15:59 AM
#3742   IMO, HUUUUUGE SQUEEEEEEZE COMING!! bleu22 01/10/17 11:07:39 AM
#3741   After what happen few months ago seems like Santo 01/10/17 08:58:34 AM
#3740   I think you will get it, good luck bleu22 01/09/17 11:10:16 PM
#3739   This will it big imo. Chart is so steez 01/09/17 11:03:11 PM
#3738   In the last week or so, lots of bleu22 01/09/17 10:59:44 PM
#3737   This looking so good. Matter off days before steez 01/09/17 10:55:48 PM
#3736   I've been hanging since the 1.20's, IMO, good bleu22 01/09/17 10:51:32 PM
#3735   Bought some yesterday at 1.37, good luck! Santo 01/09/17 10:43:41 PM
#3734   I grabbed another couple thousand on the dip bleu22 01/09/17 04:46:13 PM
#3733   Blue balls to be crushed for sure. Sinjin LaGrange 01/09/17 04:20:31 PM
#3732   20M+ short, SQUEEZE BABY!! bleu22 01/09/17 09:24:43 AM
#3731   I believe nvax will move up significantly, but tiv111 01/06/17 01:55:27 PM
#3730   THE NOVAVAX WEBSITE THAT IS. BOLD4GOLD 01/06/17 12:29:49 PM
#3729   CLINICAL TRIALS PHASE III THERAPY FOR INFANTS. WHEN BOLD4GOLD 01/06/17 12:25:02 PM
#3728   20M+ short, SQUEEZE BABY!! bleu22 01/06/17 09:56:38 AM
#3727   Has moved up a bit lately, but are r clarke 01/06/17 08:08:43 AM
#3726   Shorties better cover early. I think I'm hearing bleu22 01/05/17 07:13:21 AM
#3725   IMO, huge news coming, Jan, 20 options, $6. bleu22 12/30/16 07:43:33 PM
#3724   Dilution news out mikekrane 12/30/16 05:22:06 PM
#3723   I'm right there with you; fingers crossed. Dgoff 12/30/16 02:52:02 PM
#3722   Optimistically waiting. LOL bleu22 12/30/16 02:30:49 PM
#3721   Not much chatting going on for a few days. Dgoff 12/30/16 09:57:29 AM
PostSubject